Abstract
Breast cancer is one of the most prevalent neoplasms among women, representing a quarter of diagnosed cases and being responsible for a significant portion of annual deaths. Treatment and prognosis changed according to tumor characteristics, such as histological subtype and advanced diagnosis. Given the heterogeneity of responses to treatment, biomarkers that help predict outcomes are hig…